Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ABIO Historical Stock Prices |
| Preferred Stock Newsletter |
| ABIO Options Chain |
| Stock Message Boards |
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on January 23, 2023, ABIO opened at $2.27, traded as high as $2.30 and as low as $2.25, and closed at $2.29. Trading volume was a total of 24.10K shares. On January 24, 2023, ABIO opened at $2.25, traded as high as $2.31 and as low as $2.25, and closed at $2.27. Trading volume was a total of 33.00K shares. On January 25, 2023, ABIO opened at $2.24, traded as high as $2.30 and as low as $2.23, and closed at $2.30. Trading volume was a total of 32.30K shares. On January 26, 2023, ABIO opened at $2.33, traded as high as $2.39 and as low as $2.24, and closed at $2.27. Trading volume was a total of 23.00K shares. On January 27, 2023, ABIO opened at $2.31, traded as high as $2.31 and as low as $2.18, and closed at $2.22. Trading volume was a total of 40.10K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 01/30/2013 | |
| End date: | 01/27/2023 | |
| Start price/share: | $514.08 | |
| End price/share: | $2.22 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -99.57% | |
| Average Annual Total Return: | -41.99% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $43.22 | |
| Years: | 10.00 | |
 | |||||
| ABIO Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 01/23/2023 | $2.27 | $2.30 | $2.25 | $2.29 | 24.10K |
| 01/24/2023 | $2.25 | $2.31 | $2.25 | $2.27 | 33.00K |
| 01/25/2023 | $2.24 | $2.30 | $2.23 | $2.30 | 32.30K |
| 01/26/2023 | $2.33 | $2.39 | $2.24 | $2.27 | 23.00K |
| 01/27/2023 | $2.31 | $2.31 | $2.18 | $2.22 | 40.10K |
|
| About ARCA biopharma |
| ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. |
| ABIO Historical Closing Prices | |
| Date | Close |
| 01/23/2023 | $2.29 |
| 01/24/2023 | $2.27 |
| 01/25/2023 | $2.30 |
| 01/26/2023 | $2.27 |
| 01/27/2023 | $2.22 |
| Healthcare Historical Prices |
| ABIO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABMD Historical Stock Prices Also explore: ABIO shares outstanding history
|
Free ABIO Email Alerts:
